GSK Investigational Site

Bristol, Connecticut 06010

0 studies enrolling now · 3 studies all time

What they study most

Colitis, Ulcerative, Irritable Bowel Syndrome (IBS), Irritable Colon

Studies at this site

• A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis — Completed
• Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy — Completed
• Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS) — Completed